Silver dressings could simplify infection care for dialysis patients
NCT ID NCT07641491
First seen Jun 13, 2026 · Last updated Jun 23, 2026 · Updated 2 times
Summary
This pilot study tests whether silver-impregnated dressings can effectively manage catheter exit-site or tunnel infections in adults on peritoneal dialysis, compared to standard daily antibiotic dressings. Sixty participants will be randomly assigned to receive either the silver dressing or standard care, and will be followed for 12 weeks. The study aims to see if the silver dressing is feasible, acceptable, and leads to faster infection resolution with fewer dressing changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL DIALYSIS CATHETER EXIT SITE INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Singapore General Hospital
Singapore, 169608, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Silver-impregnated dressing
What this could lead to
If successful, this could offer a simpler, less frequent dressing option for managing catheter infections in dialysis patients, potentially reducing treatment burden.
What could go wrong
This is a small pilot study with only 60 participants, so results may not apply broadly. The dressing may not work as well as standard antibiotics, and infections could worsen.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.